Stocks · News reference

Celularity Says It Regained Compliance With Nasdaq Minimum Bid Price And Market Value Of Listed Securities Rules; Delinquent Periodic Filing Deficiency Remains Outstanding

2026-09-14 13:05:02 UTCBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

Benzinga2026-10-29 13:02:43 UTCBenzinga Newsdesk
Celularity Enters Manufacturing Agreement With Vesalius For Its Peptual-Branded Peptide Active Pharmaceutical Ingredients
CELU
SEC EDGAR2026-10-29 13:24:54 UTCSEC EDGAR
8-K filing — Celularity Inc (CELU)
Filed: 2026-10-29 AccNo: 0001493152-26-049203 Size: 236 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
CELU
Fiscal.ai2026-10-23 13:03:34 UTC
Celularity Regains Compliance with Nasdaq Periodic Financial Reporting Requirement
Celularity Inc. announced it has received confirmation from Nasdaq that it has regained compliance with the exchange's periodic financial reporting requirements following the filing of its second-quarter 2026 Form 10-Q.
CELU
Benzinga2026-10-02 05:47:25 UTCRishabh Mishra
Stock Market: Will S&P 500 Open Up or Down Today?
S&P 500 to open higher? Polymarket odds reach 70% as Wall Street digests September jobs, 24-year high Treasury yields, and Iran sanctions.
CELU DIA ENLV LNAI POLUSD
Benzinga2026-09-29 21:32:11 UTCBenzinga Newsdesk
Celularity Q1 EPS $0.02 Up From $(0.84) YoY, Sales $3.846M Down From $11.426M YoY
CELU
Benzinga2026-09-24 14:09:11 UTCBenzinga Newsdesk
Celularity shares are trading higher after the company announced an initial closing generating over $10 million in gross cash proceeds from a private placement of senior secured convertible notes and warrants.
CELU